Value Hive Podcast cover image

Peter Mantas (Logos LP): Portfolio Construction, Biotechs & Value Re-Booted

Value Hive Podcast

00:00

Is There a Risk of Recurrence?

It's hard to people may pass on them, but they're under estimated. The other thing is hardley manufacturing it in a facility they own. And arethey associated with a particular hospital? Ah, that's another thing that we look for,. especially it's a university hospital. I these are things that you'd have. It's not an complicated stuf. But there's a massofe regulatoriis, the bial tok we like, is more a som medical device.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app